Broadridge Financial Solutions (BR) — Q4 FY2026 Earnings Preview

Ticker: BR Earnings Date: August 4, 2026 Prepared: August 4, 2026 Fiscal Period: Q4 FY2026 (quarter ended June 30, 2026)

1. Earnings Preview

Key Takeaway: The setup into Q4 FY2026 is constructive — management raised both recurring revenue and EPS guidance at the Q3 print — but the closed sales shortfall and a known GTO headwind (Canton minting curve shift + license timing) keep the bar from being unambiguously low; the biggest swing factor is whether ICS regulatory revenue and equity position growth land at the high end of guidance.

Heading into Q4 FY2026, Broadridge carries raised full-year guidance — recurring revenue growth "at or above 7%" constant currency and adjusted EPS growth of 10–12% — after a Q3 beat on both revenue and EPS, giving the print a credible setup. Management explicitly guided for low double-digit equity revenue position growth and mid-to-high single-digit fund position growth in Q4, which should drive another quarter of high single-digit ICS regulatory revenue growth; consensus sits at ~$2.16B in revenue and ~$3.77 in adjusted EPS, implying low-to-mid single-digit EPS growth as management flagged. The closed sales guidance cut to $240–290M (from $290–330M) remains the key overhang, though management frames it as a timing issue given a record pipeline above $1B and 25% YoY origination growth. On the GTO side, a 3-point CQG contribution to capital markets will be offset by a 5-point license revenue headwind in wealth management, creating a known drag. The stock has recovered ~2% since the Q3 print but remains down ~36% over the trailing twelve months, trading at ~15x NTM P/E — a significant de-rating from ~31x a year ago — suggesting the market has already priced in considerable risk, which limits downside on an in-line print. The wildcard is whether management provides a constructive initial framework for the next three-year guidance cycle (FY2027–FY2029) on this call, which could be a meaningful positive catalyst given the stock's depressed valuation.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus reflects management's own Q4 guidance closely — the bar is neither heroic nor low. ICS regulatory revenue (driven by equity and fund position growth) is the primary swing factor; GTO faces a known net headwind from license timing and the Canton minting curve shift partially offset by CQG.

Table 1 — Current Quarter Snapshot (Q4 FY2026)

KPI

Q3 FY2026 Actual (Last Quarter)

Q4 FY2025 Actual (Prior Year)

Q4 FY2026 Consensus Estimate

YoY Change

Management Guidance

Consensus vs. Guidance

Total Revenue ($M)

$1,953.6M

$2,065.4M

$2,164.1M

+4.8% YoY

At or above 7% recurring rev growth (FY)

In line with guidance

Adj. EPS — Diluted Operating ($)

$2.72

$3.55

$3.77

+6.2% YoY

10–12% FY adj. EPS growth; Q4 implies low-to-mid single-digit

~+6% vs. prior year; within guided range

ICS Recurring Fee Revenue ($M)

$799.7M

$958.9M

$1,023.3M

+6.7% YoY

ICS recurring rev slightly ahead of overall 7%+ guidance; high single-digit regulatory rev growth in Q4

In line

GTO Revenue ($M)

$488.3M

$464.7M

$483.6M

+4.1% YoY

GTO 5–7% FY growth; Q4: +3pt CQG, −5pt license headwind in WM

Slightly below midpoint of FY range

Closed Sales ($M)

$57.5M

$113.5M

$135.4M

+19.3% YoY

$240–290M FY (implies ~$93–143M in Q4)

Consensus at ~$135M; within revised guidance range

Equity Position Growth (Revenue, %)

11%

18%

~5% (consensus placeholder)

N/A

Low double-digit equity revenue positions in Q4

Consensus below guidance; upside risk if positions track Q3 trend

Mutual Fund / ETF Position Growth (%)

6%

7%

~6% (consensus placeholder)

N/A

Mid-to-high single-digit fund position growth in Q4

In line with guidance

Source: Visible Alpha consensus and actuals data; BR Q3 FY2026 earnings call (April 30, 2026). Revenue and EPS figures from Visible Alpha. Position growth consensus placeholders reflect VA consensus of ~5% vs. management guidance of low double-digit equity revenue positions — a notable divergence that represents upside risk if Q3 trends persist.

Table 2 — Beat/Miss History: Top 2 KPIs (Last 8 Quarters)

Quarter

KPI

Reported

Consensus Est.

Surprise %

Result

Q3 FY2026

Revenue ($M)

$1,953.6M

$1,902.7M

+2.7%

Beat

Q3 FY2026

Adj. EPS ($)

$2.72

$2.59

+5.0%

Beat

Q2 FY2026

Revenue ($M)

$1,713.9M

$1,608.8M

+6.5%

Beat

Q2 FY2026

Adj. EPS ($)

$1.59

$1.37

+16.1%

Beat

Q1 FY2026

Revenue ($M)

$1,589.4M

$1,537.9M

+3.3%

Beat

Q1 FY2026

Adj. EPS ($)

$1.51

$1.25

+20.8%

Beat

Q4 FY2025

Revenue ($M)

$2,065.4M

$2,054.6M

+0.5%

Beat

Q4 FY2025

Adj. EPS ($)

$3.55

$3.50

+1.4%

Beat

Q3 FY2025

Revenue ($M)

$1,811.7M

$1,859.1M

−2.6%

Miss

Q3 FY2025

Adj. EPS ($)

$2.44

$2.42

+0.8%

Beat

Q2 FY2025

Revenue ($M)

$1,589.2M

$1,547.0M

+2.7%

Beat

Q2 FY2025

Adj. EPS ($)

$1.56

$1.49

+4.7%

Beat

Q1 FY2025

Revenue ($M)

$1,422.9M

$1,496.0M

−4.9%

Miss

Q1 FY2025

Adj. EPS ($)

$1.00

$0.99

+1.0%

Beat

Pattern: BR has beaten adjusted EPS consensus in 7 of the last 8 quarters, with the sole revenue miss in Q1 FY2025 and Q3 FY2025 driven by seasonal timing and distribution revenue dynamics rather than underlying demand weakness; the consistent EPS beat pattern reflects management's conservative guidance philosophy and operating leverage discipline. Source: Visible Alpha consensus and actuals data.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance has been raised twice since the start of FY2026 — most recently at the Q3 print on April 30, 2026 — and has been consistently reaffirmed at three investor conferences since then (Needham May 12, Bernstein May 27, RBC June 9). No post-earnings guidance changes have been issued via 8-K; tone at conferences is constructive and consistent with the April 30 framework.

Metric

Initial Guidance (Q3 FY2026 Earnings Call — April 30, 2026)

Revised Guidance

Current Consensus

Note

FY2026 Recurring Revenue Growth (CC)

At or above 7%

~7.4% implied by VA consensus

Reaffirmed at Needham (May 12), Bernstein (May 27), and RBC (June 9) conferences; no change

FY2026 Adjusted EPS Growth

10–12%

~10.5% implied by VA consensus ($9.56 vs. $8.65 FY2025)

Reaffirmed at all three post-earnings conferences; tone confident

FY2026 AOI Margin

~20–21%

~20% (consistent with guidance)

Unchanged; Q4 expected to show similar margin dynamic to Q3 (21.5% AOI margin in Q3)

FY2026 Closed Sales

$240–290M (cut from $290–330M at Q3 print)

~$282M (VA consensus)

Lowered at Q3 earnings (April 30, 2026); attributed to elongated deal cycles on larger engagements, not demand deterioration; pipeline at record >$1B

Q4 FY2026 ICS Regulatory Revenue

High single-digit growth

Consistent with guidance

Driven by low double-digit equity revenue positions + mid-to-high single-digit fund positions

Q4 FY2026 GTO Capital Markets

+3pt contribution from CQG; −5pt license headwind in WM

Net modest headwind expected

CQG closed April 30, 2026; Canton minting curve shift to application rewards creates known headwind

FY2026 Free Cash Flow Conversion

Over 100%

On track per management

Reaffirmed at Q3 earnings; leverage ratio at 1.9x, below 2.0–2.5x target

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been modestly revised upward since the Q3 print on April 30, 2026, tracking management's raised guidance. The gap between current consensus and guidance is narrow, suggesting the bar is fairly set — no meaningful cushion or risk from estimate drift.

KPI (Period)

Estimate ~5 Days Post Q3 Earnings (as of May 7, 2026)

Current Consensus

Estimate Δ (%)

Initial Guidance (Q3 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Revenue — Q4 FY2026

$2,161.6M

$2,164.1M

+0.1%

At or above 7% recurring rev growth (FY)

Unchanged

In line

Revenue — FY2026

$7,418.5M

$7,420.9M

+0.0%

At or above 7% recurring rev growth

Unchanged

In line

Revenue — FY2027

$7,757.8M

$7,764.3M

+0.1%

Next 3-yr cycle expected to look "very similar" to current cycle

Unchanged

Consistent with continuation of 7–9% recurring rev growth

Adj. EPS — Q4 FY2026

$3.75

$3.77

+0.5%

10–12% FY adj. EPS growth; Q4 implies low-to-mid single-digit

Unchanged

In line with guidance

Adj. EPS — FY2026

$9.55

$9.56

+0.1%

10–12% FY adj. EPS growth

Unchanged

At low end of 10–12% range

Adj. EPS — FY2027

$10.37

$10.41

+0.4%

Next 3-yr cycle: 8–12% EPS growth expected

Unchanged

~9% growth; within expected range

Closed Sales — FY2026

$282.2M

$282.2M

0.0%

$240–290M (cut from $290–330M)

Unchanged

Near top of revised range; requires strong Q4 close

Source: Visible Alpha consensus and actuals data. Estimate baseline as of May 7, 2026 (approximately 5 trading days post Q3 FY2026 earnings on April 30, 2026). Estimates have been remarkably stable since the Q3 print, with virtually no revision drift — suggesting the street has high confidence in management's guidance framework and is not pricing in meaningful upside or downside from current levels.

5. Stock Performance

Key Takeaway: BR's stock performance since the Q3 earnings print has been driven almost entirely by multiple contraction rather than estimate revisions — the NTM P/E has compressed from ~31x a year ago to ~15x today, a ~51% de-rating, while EPS estimates have been largely stable. The stock is up ~2% since the April 30 print but down ~36% over the trailing twelve months, significantly underperforming both XLK (+12% since print) and the S&P 500 (+5% since print).

BR vs. XLK vs. S&P 500 — Indexed to 100 at Q3 FY2026 Earnings (April 30, 2026). BR +2.2%, XLK +11.6%, SPY +5.4% through August 4, 2026. Sector ETF: XLK (Technology Select Sector SPDR). Source: Yahoo Finance / Stock Price Data.

Performance Decomposition (trailing 12 months): BR is down ~36% over the past year. The NTM EV/EBITDA multiple has compressed from ~18x to ~11x (−40%), while NTM P/E has compressed from ~31x to ~15x (−51%). Estimate revisions have been modestly negative (adj. EPS estimates for the current quarter declined from ~$3.56 in August 2025 to ~$3.41 in July 2026, a ~4% downward drift), but the overwhelming driver of underperformance has been multiple contraction. Management explicitly acknowledged the stock's underperformance at the Bernstein conference (May 27, 2026), attributing it to: (1) sector-wide reallocation toward hyperscalers and large AI names; (2) investor uncertainty about whether AI is a tailwind or headwind for BR; and (3) a tokenization bear case concern about recurring revenue model disruption. At ~15x NTM P/E, the stock trades at a significant discount to its 5-year average and to the broader fintech peer group, suggesting the market has priced in a more adverse scenario than management's guidance implies.

6. Peer Commentaries / Read-Throughs (Last 60 Days)

Key Takeaway: Peer commentary from ADP (reported July 29), FactSet (reported July 1), SS&C Technologies (reported July 23), and Paychex (reported June 24) is broadly constructive for BR — all four peers reported strong demand, robust pipelines, AI as a revenue tailwind, and healthy wealth/asset management technology spending. The most directly relevant read-through is FactSet's confirmation that AI is driving incremental client spending and longer-duration contracts in financial data/technology, and SS&C's commentary on robust demand for outsourcing and tokenized product infrastructure.

Note on Peer Selection: Only commentary from peers' most recently reported quarters (i.e., their current reporting period or forward-looking commentary issued after their own last earnings) is included below. Prior-quarter results commentary has been excluded. All four peers below reported within the last 60 days and provided forward-looking commentary relevant to BR's Q4 FY2026 setup.

6.1 ADP (Reported July 29, 2026 — FY2027 Outlook)

Relevance to BR: Medium-High. ADP is a large-cap fintech/HCM peer with overlapping client base (financial institutions, large enterprises) and similar AI investment thesis. ADP's FY2027 guidance and commentary on AI, pricing, and demand provide a useful macro read-through for BR's financial technology and wealth management segments.

6.2 FactSet Research Systems (FDS) (Reported July 1, 2026 — FQ3 2026 Results & FQ4 Outlook)

Relevance to BR: High. FactSet is a direct peer in financial data and technology services, serving overlapping clients (asset managers, banks, hedge funds). FDS's commentary on AI monetization, wealth management technology spending, and contract terms is highly relevant to BR's ICS and GTO segments.

6.3 SS&C Technologies (SSNC) (Reported July 23, 2026 — Q2 2026 Results & H2 Outlook)

Relevance to BR: High. SS&C is a direct competitor and peer in financial technology, fund administration, and wealth management. SSNC's commentary on outsourcing demand, tokenization infrastructure, and AI-driven margin expansion is directly relevant to BR's GTO and ICS segments.

6.4 Paychex (PAYX) (Reported June 24, 2026 — FY2027 Outlook)

Relevance to BR: Medium-Low. Paychex is a large-cap HCM/payroll peer with limited direct overlap with BR's financial markets infrastructure business. Read-through is primarily on macro stability, AI adoption, and pricing power in enterprise technology.

7. Material News & Developments

Key Takeaway: The most material post-earnings development is the May 15, 2026 $500M senior notes offering (5.750% due 2036), which extends BR's debt maturity profile and signals financial flexibility. Multiple strategic product launches in tokenization and AI since the Q3 print reinforce the long-term growth narrative but are unlikely to move Q4 numbers materially.

8. Insider Transaction Activity

Key Takeaway: Insider activity since the Q3 print is minimal — a single open-market sale by the Chief Legal Officer in early June. No open-market purchases have been disclosed. The absence of insider buying at a 52-week low is notable but not alarming given that management has been active with buybacks at the corporate level ($350M YTD through Q3).

Name

Title

Transaction Type

Shares

Transaction Date

Filing Date

Note

Jarkowski, Hope M.

Chief Legal Officer

Open Market Sale

1,966 shares

June 4, 2026

June 5, 2026

Discretionary sale; 1,250 shares remaining post-transaction. Not flagged as 10b5-1 planned sale.

Source: SEC Form 4 filings database. Open-market transactions only (Form 4 codes P/S). Effective date (transaction date) and disclosure date (filing date) are distinguished above. No open-market purchases or 10b5-1 plan initiations identified in the period from April 30, 2026 through August 4, 2026. The single discretionary sale by the CLO is small in size and not indicative of a negative signal; the remaining share count of 1,250 post-transaction is modest. Corporate-level buybacks ($350M YTD through Q3 FY2026) represent the more meaningful capital allocation signal.

9. Key Risks and Watch Items

Key Takeaway: The primary risks heading into Q4 are execution on closed sales (must deliver ~$93–143M in Q4 to hit revised guidance), the GTO net headwind from license timing and Canton minting curve shift, and whether management provides a constructive initial framework for the next three-year guidance cycle. Upside risk centers on position growth exceeding guidance and the next-cycle guidance announcement.

Disclosures & Data Sources

This earnings preview is prepared for informational purposes only and does not constitute investment advice. All financial estimates and consensus data sourced from Visible Alpha unless otherwise noted. Stock price data sourced from Yahoo Finance. Insider transaction data sourced from SEC Form 4 filings database. Peer commentary sourced from earnings call transcripts and conference transcripts via Implied financial documents database. All figures in USD unless otherwise stated.

Key Sources: BR Q3 FY2026 Earnings Call Transcript (April 30, 2026); BR Needham Technology, Media & Consumer Conference Transcript (May 12, 2026); BR Bernstein Strategic Decisions Conference Transcript (May 27, 2026); BR RBC Capital Markets Financial Technology Conference Transcript (June 9, 2026); BR 8-K — $500M Senior Notes Offering (May 15, 2026); ADP Q4 FY2026 Earnings Call Transcript (July 29, 2026); FDS Q3 FY2026 Earnings Call Transcript (July 1, 2026); SSNC Q2 2026 Earnings Call Transcript (July 23, 2026); PAYX Q4 FY2026 Earnings Call Transcript (June 24, 2026); Visible Alpha Consensus and Actuals Data; SEC Form 4 Filings Database; Yahoo Finance Stock Price Data.